Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
12 Pharmacogenetics of drug transportersDanesi, REuropean journal of cancer supplements, 2010, Vol.8 (7), p.14-14 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
145PExpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical response to CDK4/6 inhibitors in breast cancerCrucitta, S ; Del Re, M ; Fontana, A ; Bertolini, I ; Rofi, E ; De Angelis, C ; Diodati, L ; Cavallero, D ; Salvadori, B ; Falcone, A ; Morganti, R ; Danesi, RAnnals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
1561P - Incidence of T790M in NSCLC patients progressed to gefitinib, erlotinib, and afatinib: A study on circulating tumour DNADanesi, R. ; Petrini, I. ; Mazzoni, F. ; Valleggi, S. ; Gianfilippo, G. ; Pozzessere, D. ; Crucitta, S. ; Restante, G. ; Chella, A. ; Garassino, M.C. ; Miccoli, M. ; De Re, M.l.Annals of oncology, 2019-10, Vol.30, p.v643-v643 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
1561PIncidence of T790M in NSCLC patients progressed to gefitinib, erlotinib, and afatinib: A study on circulating tumour DNADanesi, R ; Petrini, I ; Mazzoni, F ; Valleggi, S ; Gianfilippo, G ; Pozzessere, D ; Crucitta, S ; Restante, G ; Chella, A ; Garassino, M C ; Miccoli, M ; Re, M DelAnnals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
1616PLIQUID BIOPSY TO MONITOR THE EVOLUTION OF NSCLC EGFR+DURING TREATMENT WITH GEFINTINIBSpada, D ; Del Re, M ; Citi, V ; Guarino, S ; Ficarelli, R ; Testa, E ; Danesi, RAnnals of oncology, 2014-09, Vol.25 (suppl_4), p.iv559-iv559 [Periódico revisado por pares]Oxford University PressTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
167P Exploring the role of rare germline variants in non-coding regions of cancer predisposition genes in triple-negative breast cancer patientsPalleschi, M. ; Virga, A. ; Fonzi, E. ; Scarpi, E. ; Merloni, F. ; Sarti, S. ; Zampiga, V. ; Cangini, I. ; Calistri, D. ; Bandini, E. ; Danesi, R. ; Ravegnani, M. ; Casadei, C. ; Sirico, M. ; Falcini, F. ; Mannozzi, F. ; Tegas, M. ; De Giorgi, U. ; Ulivi, P. ; Tedaldi, G.ESMO open, 2024-05, Vol.9, p.103189, Article 103189 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
169PSelective induction of PD-L1 expression in plasma-derived exosomes by gemcitabine-nab-paclitaxel vs. FOLFIRINOX in pancreas cancerRofi, E ; Del Re, M ; Vivaldi, C ; Crucitta, S ; Arrigoni, E ; Pasquini, G ; Catanese, S ; Pecora, I ; Musettini, G ; Vasile, E ; Falcone, A ; Danesi, RAnnals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
176PReal-world treatment patterns for metastatic non-small cell lung cancer at IRST ItalyAltini, M ; Massa, I ; Balzi, W ; Gentili, N ; Foca, F ; Danesi, V ; Manunta, S ; Burgio, M A ; Cravero, P ; Ejzykowicz, F ; Chandwani, S ; Delmonte, AAnnals of oncology, 2019-04, Vol.30 (Supplement_2) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
1932MO Ki67 expression and CDK4/6i activity: An emerging role for PIK3CA mutations in metastatic breast cancer patientsDel Re, M. ; Lorenzini, G. ; Cucchiara, F. ; De Angelis, C. ; Crucitta, S. ; Diodati, L. ; Cavallero, D. ; Bargagna, I. ; Cinacchi, P. ; Fratini, B. ; Salvadori, B. ; Fontana, A. ; Danesi, R.Annals of oncology, 2020-09, Vol.31, p.S1093-S1093 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
228PPATTERN OF DIHYDROPYRIMIDINE DEHYDROGENASE GENETIC VARIANTS IN PATIENTS WITH VARIOUS DEGREES OF TOLERABILITY OF FLUOROPYRIMIDINE TREATMENTDel Re, M ; Pietrantonio, F ; Palombi, M ; Sameen, S ; Loupakis, F ; Barbara, C ; Latiano, T ; Ulivi, P ; Zafarana, E ; Passardi, A ; Maiello, E ; Brandes, A ; Cappuzzo, F ; Siena, S ; De Braud, F.G.M ; Falcone, A ; Labianca, R ; Zamagni, C ; Pinto, C ; Danesi, RAnnals of oncology, 2014-09, Vol.25 (suppl_4), p.iv77-iv77 [Periódico revisado por pares]Oxford University PressTexto completo disponível |